Anindya Bhattacharya

Neuroscience

Anindya Bhattacharya is Head of Neuroscience at Switch Therapeutics, and previously was Senior Director and Head of Neuroimmunology at Janssen, San Diego.
More from Anindya

JNJ-54175446

JNJ-54175446 is an oral, CNS-penetrant P2X7 ion channel antagonist targeting a novel pathway linking neuroinflammation and depression, with recently published Ph. I data in major depressive disorder (NCT02902601, initiated in 2016). The Janssen program is notable as a pioneering early example of a neuroinflammation program started at a time before NLRP3 or neuroimmunology were commonly discussed topics, as they are today [...]

Molecule

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >8,000 drug hunters worldwide. Unsubscribe anytime.